Worldwide Market Reports

Vaccine Technologies Market with Innovations, Competitive Analysis and New Business Developments – Forecast to 2027

This report studies the Vaccine Technologies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyses the top players in global market, and splits the Vaccine Technologies market by product type and applications/end industries.


Seattle, WA -- (SBWIRE) -- 11/26/2019 -- Vaccine Technologies:
The past decades have witnessed the development of a wide array of new vaccination technologies ranging from targeted attenuation techniques of live pathogens to the delivery of biologically engineered protein and peptide antigens as well as viral vector and nucleic acid based antigens.
Rising number of diseases and increasing population across the globe is positively affecting the vaccine technologies market size during the study period. Development of immunization programs across the emerging countries will support in increasing industry volume. Emergence of new pandemics will enhance the business growth. Vaccines can significantly reduce the burden of various diseases and can increase life expectancy through prevention.

For More Info and For a Sample:

The report intends to explain the critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to the stakeholders and potential entrants. This report is designed to be a critical decision-making tool for the intended audience, which includes vaccine market players, potential entrants and other professionals involved with, or interested in, immunology and vaccine-preventable diseases. This study contributes to the areas of market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings as well as pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

Seasonal influenza vaccine production doubled, from 500 million annually to 1 billion annually, between 2006 and 2010, the report notes. More than a dozen developing nations, from South Africa to Kazakhstan, have been awarded grants to establish manufacturing centers for domestic influenza vaccines, and as of 2017 five nations – India, Indonesia, South Korea, Thailand and Romania – had vaccines in the late-stage development phase. Financial support for this effort has come from the U.S., Japan, the Asian Development Bank, Canada and the U.K. The trend for vaccine manufacturing, the report adds, is toward increased capacity, with vaccines being applied to cancer prevention efforts, seasonal flu prevention and concerns over pandemics.

Global vaccine technologies market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional vaccine technologies market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

The introduction of newer vaccines covering many diseases is another factor pushing the market towards significant growth. New product offerings to meet unmet needs, contingency planning for pandemic infections, awareness of diseases prevention, improving economic conditions of developing countries and increasing interest and investments from major pharmaceutical companies are shaping the vaccines market.

The report provides useful information to all the market players, potential entrants, government agencies and other interested parties. As the report also covers various geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Company profiles of major key players in the market:
Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson, Thermo Fisher Scientific.

Market Segment by Type:
Infection, Allergy, Cancer.

Market Segment by Applications:
Humans, Animals.

Report Includes:
- An overview of the global market for vaccine technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2027
- A review of vaccine technology and its challenges, innovations, opportunities, and regulatory hurdles
- Evaluations of market sizes and developments for vaccine classes (prophylactic and therapeutic), vaccine types (inactivated, conjugate, attenuated, recombinant vector, subunit, toxoid, combination, and dendritic cells), vaccine end users (humans and animals) and disease indications (infectious, cancer, and allergy)
- Examination of the industry environment, strategies, market influences, and driving forces
- Identification of regional market sizes, prices, and trends
- Analysis of relevant patents

Place an Inquire before Purchase:

Table of Contents
1 Vaccine Technologies Market Overview
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Vaccine Technologies Type and Applications Product A Product B
2.1.3 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Vaccine Technologies Market Competition, by Players
4 Global Vaccine Technologies Market Size by Regions
5 North America Vaccine Technologies Revenue by Countries